Observational studyJournal of robotic surgery2023
Novel approaches utilizing robotic navigational bronchoscopy: a single institution experience.
Observational study in Journal of robotic surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.
- Robotic-assisted bronchoscopy for the diagnosis of peripheral pulmonary lesions: A systematic review and meta-analysis.Thoracic cancer · 2024Pooled it
- Shape sensing robotic assisted bronchoscopy versus virtual bronchoscopic navigation in the diagnosis of peripheral pulmonary nodules.Scientific reports · 2025Article
- Outcomes of Robot-Assisted Transbronchial Biopsies of Pulmonary Nodules: A Review.Diagnostics (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 2 countries.
Funding
Abstract
The effective biopsy of pulmonary nodules is crucial to early diagnosis and consequent effective treatment for patients. As a relatively new procedure, few studies look at the effectiveness of the Monarch system in achieving this goal. The aim of this study is to describe the validity of the Monarch-guided robotic navigational bronchoscopy as an effective diagnostic method for pulmonary disease. A secondary aim is to describe the validity of dye localization using the robotic platform to improve the diagnostic accuracy of surgical biopsies in suspicious subcentimeter nodules. This observational cohort study includes patients who underwent robotic navigational bronchoscopy at John Muir Health between July 8, 2020 and October 11, 2021. Some underwent the navigational bronchoscopy in conjugation with a dye localization procedure. Patient data were collected from the institutional database. We measured specificity, sensitivity, and likelihood ratios. A total of 69 patients underwent robotic navigational bronchoscopy. The procedure had a specificity and sensitivity of 100% and 91.3%, respectively. Additionally, 28 patients underwent robotic navigational bronchoscopy in conjugation with dye localization. The specificity and sensitivity for the combined procedures was 100% and 100%, respectively. Robotic Navigational Bronchoscopy can be a successful diagnostic technique to diagnose pulmonary disease quickly and accurately. The technique allowed for the effective biopsy of traditionally difficult to access nodules. Additionally, by combining dye localization techniques, surgical biopsy of the nodules significantly improved the diagnostic accuracy. This single anesthetic event can potentially lead to earlier diagnosis, staging, and treatment of early stage lung cancers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.